Skip to main content
. 2022 Jan 18;13(2):2889–2901. doi: 10.1080/21655979.2022.2025700

Figure 1.

Figure 1.

TMPO-AS1 was a key lncRNA in CHOL. (a) TCGA showed expression of TMPO-AS1 in multiple human cancers. (b) TCGA showed the expression of TMPO-AS1 in CHOL. (c) qRT-PCR detected the expression of TMPO-AS1 in CHOL tissues and normal tissues. (d) qRT-PCR detected the expression of TMPO-AS1 in CHOL cell lines (HCCC9810, HuCCT1 and RBE) and human intrahepatic biliary epithelial cell line (HIBEC). *P < 0.05, **P < 0.01 vs. HIBEC. (e) qRT-PCR identified the transfection efficiency of sh-TMPO-AS1-1 and sh-TMPO-AS1-2. sh-TMPO-AS1-1 and sh-TMPO-AS1-2 were two siRNAs targeting TMPO-AS1. NC, negative control. **P < 0.01 vs. sh-NC.